CXCL3 and its receptor CXCR2 have been recently found overexpressed in prostate cancer cells, prostate epithelial cells and prostate cancer tissues, which may implicate a role for this chemokine in prostate cancer progression and metastasis (32). This evidence concerns the gene CXCR2 and prostate cancer.